Restoration of tumor immunosurveillance via targeting of interleukin-13 receptor-alpha 2. - Wikidata - awgldk - TriplyDB

Restoration of tumor immunosurveillance via targeting of interleukin-13 receptor-alpha 2.

Restoration of tumor immunosurveillance via targeting of interleukin-13 receptor-alpha 2.

http://www.wikidata.org/entity/Q37353748

about

Myeloid-derived suppressor cells: linking inflammation and cancer The role of NKT cells in tumor immunity Mesenchymal Stem Cells and Myeloid Derived Suppressor Cells: Common Traits in Immune Regulation CD8⁺ T Cell-Independent Immune-Mediated Mechanisms of Anti-Tumor Activity NKT cell networks in the regulation of tumor immunity Molecular Basis for Shared Cytokine Recognition Revealed in the Structure of an Unusually High Affinity Complex between IL-13 and IL-13Rα2 IL-13 signaling via IL-13Rα2 triggers TGF-β1-dependent allograft fibrosis Blockade of TGF-beta enhances tumor vaccine efficacy mediated by CD8(+) T cells.Strategies to use immune modulators in therapeutic vaccines against cancer Mouse and human iNKT cell agonist β-mannosylceramide reveals a distinct mechanism of tumor immunity.Tumor development in murine ulcerative colitis depends on MyD88 signaling of colonic F4/80+CD11b(high)Gr1(low) macrophages.Glioma IL13Rα2 is associated with mesenchymal signature gene expression and poor patient prognosis Chitinase 3-like-1 and its receptors in Hermansky-Pudlak syndrome-associated lung disease.Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma.Mouse CD11b+Gr-1+ myeloid cells can promote Th17 cell differentiation and experimental autoimmune encephalomyelitis.Stem-like tumor-initiating cells isolated from IL13Rα2 expressing gliomas are targeted and killed by IL13-zetakine-redirected T Cells The Metabolic Prospective and Redox Regulation of Macrophage Polarization.Targeting of interleukin-13 receptor α2 for treatment of head and neck squamous cell carcinoma induced by conditional deletion of TGF-β and PTEN signaling.Myeloid derived suppressor cells: Targets for therapy.Ranitidine modifies myeloid cell populations and inhibits breast tumor development and spread in mice.IL-13Rα2 uses TMEM219 in chitinase 3-like-1-induced signalling and effector responses.Myeloid-derived suppressor cells and myeloid regulatory cells in cancer and autoimmune disorders Chitinase 3-like 1 regulates cellular and tissue responses via IL-13 receptor α2 Myeloid cells in the tumor microenvironment: modulation of tumor angiogenesis and tumor inflammation.Role of transforming growth factor-β in inflammatory bowel disease and colitis-associated colon cancer.Immune responses triggering colitis and colitis-associated carcinoma.IL-13 receptor-directed cancer vaccines and immunotherapy.Targeting of the tumor necrosis factor receptor superfamily for cancer immunotherapy.Significance of interleukin-13 receptor alpha 2-targeted glioblastoma therapy.Role of chitinase 3-like-1 and semaphorin 7a in pulmonary melanoma metastasis.Effects of lentiviral vector-mediated TRADD expression on the inhibition of hypertrophic scar formation.A cytokine signal inhibitor for rheumatoid arthritis enhances cancer metastasis via depletion of NK cells in an experimental lung metastasis mouse model of colon cancer.Myeloid cells in tumor inflammation.Cytokine Expression and Macrophage Localization in Xenograft and Allograft Tumor Models Stimulated with Lipopolysaccharide.The Role of Natural Killer T Cells in Cancer-A Phenotypical and Functional Approach.Possible Therapeutic Application of Targeting Type II Natural Killer T Cell-Mediated Suppression of Tumor Immunity.Tissue-Specific Roles of NKT Cells in Tumor Immunity Dietary Supplementation of Selenoneine-Containing Tuna Dark Muscle Extract Effectively Reduces Pathology of Experimental Colorectal Cancers in Mice

P2860

Q24641811-E941635D-AE8A-4424-9BC7-257505EBDE31 Q24648939-FE87A64C-BF62-45F2-8CB5-F3738FFDAC86 Q26741252-F0D36454-EE23-42B4-AA45-030BF7F82A3E Q26782520-9B88C1D7-2C65-4DE8-B656-7887B79F9E64 Q26866223-E7980D61-775E-4E2C-8B53-F9353ADCEC84 Q27660192-686428D1-A108-427C-82FC-A7F0D109BF1B Q33590677-C6CE6CF8-54CA-4C72-8488-58097EEF29CC Q33637647-0B7609AF-AC34-4465-BF8A-342227B47D07 Q34275601-B8094F1D-839E-4203-9548-415244D7BF73 Q34519826-15B97816-59B9-42D4-B02E-31D6692F7BA2 Q34876594-1E239C85-6637-41E9-800F-2E6BB1A8F591 Q35035593-8DE83190-E39D-4C31-A40A-A26ED837327C Q36040475-2A607FF2-5099-4779-A608-153CD2FD6FFA Q36248008-31870718-D47E-4E08-B68E-BF564319524C Q36339119-AEB8B3D3-5967-486F-96ED-21C328C8D304 Q36626774-94D309BB-C62B-4870-852F-02E1D03E0BE3 Q36659528-10628CCA-A2C6-4904-9ACB-D61A53A59D1F Q36686360-940489B3-963F-4B0B-B5A8-3EA00AAB2955 Q36845851-EE139A00-7F1E-45A4-8AEF-3A0C7A48BBA3 Q37222105-865AC0B4-1F0E-4AFD-AA9E-B1E097310DBA Q37264739-6D79AFC5-15C3-45BA-8D96-058BC226D3B2 Q37697695-B483E80E-851F-4F4B-B444-000A3EE7BBCD Q37705711-8C1D405A-BE87-4C9F-B068-725AB11973DB Q37758250-43ECB6C5-9EBA-427F-8310-CA3139464E52 Q37789682-54F30F90-FD7E-401E-AC99-899B481E9CE3 Q37989833-5FAEA0C2-F427-4939-A000-F8FA840803F5 Q38003478-DE603DD2-D337-4334-85E5-3E2C46168006 Q38120535-44522F68-9081-4466-BE62-39A086A5A006 Q38203856-34573C5A-95A8-488E-857F-23CA69E47581 Q38928339-B9AC4AAA-3861-4EF3-B115-8B7DDA7842F6 Q38981579-F50B1910-2F56-4644-9665-1DBDBA92CACA Q41612628-2112DA34-31FF-4DCF-AE8C-65D63C4AECDB Q42408323-47BC56F6-01EB-409F-9054-E4CB97F64980 Q52310791-2D53D7C0-EFEB-4AF6-8822-A2E2B2A2685D Q55094012-A6B9A3EA-7D35-4132-97D4-5C40B300CF69 Q55267052-1E1CC7EE-15D8-4394-97DD-656EEFAE8DD3 Q58777562-AA2460F8-0C59-48B7-AAC2-434E12B67BC8 Q59126825-FD974A11-E364-4026-A38B-B3706BC68470

P2860

Restoration of tumor immunosurveillance via targeting of interleukin-13 receptor-alpha 2.

http://www.wikidata.org/entity/Q37353748

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on May 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Restoration of tumor immunosurveillance via targeting of interleukin-13 receptor-alpha 2.

@en

Restoration of tumor immunosurveillance via targeting of interleukin-13 receptor-alpha 2.

@nl

type

label

Restoration of tumor immunosurveillance via targeting of interleukin-13 receptor-alpha 2.

@en

Restoration of tumor immunosurveillance via targeting of interleukin-13 receptor-alpha 2.

@nl

prefLabel

Restoration of tumor immunosurveillance via targeting of interleukin-13 receptor-alpha 2.

@en

Restoration of tumor immunosurveillance via targeting of interleukin-13 receptor-alpha 2.

@nl

P1433

Q37353748-AFB650FD-9BAB-4629-AC08-628D7C0958CB

P1476

Q37353748-3F4AE3E9-F2DC-4E46-AA11-AD5D4C007C89

P2093

Q37353748-250D60E6-2A72-433B-B774-67C59DDDE99B

Q37353748-450DB4F4-6360-4D16-9866-D7C49B010122

Q37353748-4C093727-0B71-450E-A5FE-C6DCE896975A

Q37353748-59BB1D4B-84FE-45F7-A3BB-250B0C40B6AE

Q37353748-7525EA9D-F91F-4817-94BD-91FC8F7B8A94

Q37353748-8F1813C7-CDF5-41E4-83D6-00A9D84834A2

Q37353748-A5D3A539-66AF-47B0-B2D8-7FFFF0C4AB2A

Q37353748-AD131EAC-6440-493F-B8A3-3F03D55E73EC

Q37353748-F9165795-2EB7-4056-B0EA-F616C638E21C

P2860

Q37353748-12BDDBC4-C599-4C8D-859A-2E6E9CE5F7A6

Q37353748-28254B1F-ED34-4F22-B39A-C793D5AEFFBA

Q37353748-2C91F9F1-B076-46D8-BEFF-1E458A22F1C5

Q37353748-36AD60F6-E7F7-4D4D-9451-A40381696086

Q37353748-432513DB-92FA-406D-862A-2DCC003DC059

Q37353748-4B89CCB6-28A5-4101-908B-8838D71D316C

Q37353748-5BCC1AAB-4F47-4AB9-85E9-F7F81068E543

Q37353748-7FEB8FAF-3555-461D-B889-FDC40C183AD7

Q37353748-852833C1-2A2A-419C-BFAB-C80EEC77C107

Q37353748-8B43768C-F44D-4FD6-B85A-96461F6B608B

P304

Q37353748-0CC9CC6C-2007-4349-AFE0-EDA1BEF2F235

P31

Q37353748-9F27578E-AD5C-480A-88DC-F692C65D6BD5

P356

Q37353748-342E184F-BEB1-4C71-B11C-D288170D3F20

P407

Q37353748-1FAE923C-5ECE-4F20-9D7B-FE3BBF67EEA9

P433

Q37353748-918D5C94-67F5-4B58-BC49-80DDE7FE9BCF

P478

Q37353748-5B85FD5C-4592-4856-8E00-78E5591BE9DE

P577

Q37353748-D909A97A-AE7E-4732-9531-D1CE0EFA2B3F

P5875

Q37353748-2D9E3ABD-D3DB-41F8-A421-2C5C396EF391

P698

Q37353748-00082C79-72A4-489E-B242-D7B46F978357

P921

Q37353748-f1ae6404-6e1d-46b4-9d71-da9d04516dac

P932

Q37353748-76B78FD4-0B2E-4586-A00D-33A123D021B7

P356

0008-5472.CAN-07-5301

P1433

Cancer Research

P1476

Restoration of tumor immunosurveillance via targeting of interleukin-13 receptor-alpha 2.

@en

P2093

Atsushi Kitani

http://www.w3.org/2001/XMLSchema#string

Cheryl A Young

http://www.w3.org/2001/XMLSchema#string

Edward K Geissler

http://www.w3.org/2001/XMLSchema#string

Hans-Jürgen Schlitt

http://www.w3.org/2001/XMLSchema#string

Ivan Fuss

http://www.w3.org/2001/XMLSchema#string

Jay A Berzofsky

http://www.w3.org/2001/XMLSchema#string

Masaki Terabe

http://www.w3.org/2001/XMLSchema#string

Stefan Fichtner-Feigl

http://www.w3.org/2001/XMLSchema#string

Warren Strober

http://www.w3.org/2001/XMLSchema#string

P2860

The murine IL-13 receptor alpha 2: molecular cloning, characterization, and comparison with murine IL-13 receptor alpha 1

IL-4/IL-13 signaling beyond JAK/STAT

IL-13 effector functions

IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis

Isolated hepatic perfusion for unresectable hepatic metastases from colorectal cancer.

Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo.

Natural killer T (NKT) cells and their role in antitumor immunity.

IL-13 receptors and signaling pathways: an evolving web.

Sustained durability and tolerability of etanercept in ankylosing spondylitis for 96 weeks

Role of IL-13 in regulation of anti-tumor immunity and tumor growth.

P304

3467-3475

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-07-5301

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

68

http://www.w3.org/2001/XMLSchema#string

P577

2008-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5401815

http://www.w3.org/2001/XMLSchema#string

P698

18451175

http://www.w3.org/2001/XMLSchema#string

P921

P932

2746996

http://www.w3.org/2001/XMLSchema#string